RecruitingPhase 4NCT06940830

Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa

Studying Hemophilia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Swedish Orphan Biovitrum
Principal Investigator
Study Physician
Swedish Orphan Biovitrum AB (publ)
Intervention
Efanesoctocog alfa(drug)
Enrollment
250 enrolled
Eligibility
All sexes
Timeline
2025 – 2028

Study locations (27)

Collaborators

PSI CRO

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06940830 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials